Wall Street analysts are making waves with their recent upgrades for several prominent companies. These changes signify a shift in sentiment and potential growth opportunities for investors.
Citigroup analyst Douglas Irwin has upgraded Delek Logistics Partners, LP (DKL) from Neutral to Buy, raising the price target from $44 to $45. This optimistic outlook comes despite Delek Logistics shares closing down 0.4% at $38.83 on Tuesday.
Meanwhile, B of A Securities analyst Ruplu Bhattacharya has upgraded Concentrix Corporation (CNXC) from Underperform to Neutral, boosting the price target from $65 to $85. Concentrix shares saw a positive reaction, rising 0.9% to close at $72.34 on Tuesday.
HSBC analyst Yifeng Liu has upgraded Moderna, Inc. (MRNA) from Reduce to Hold, setting a price target of $82. However, Moderna shares experienced a downturn, closing at $78.98, down 3.3% on Tuesday.
Deutsche Bank analyst Bastian Synagowitz has upgraded ArcelorMittal S.A. (MT) from Hold to Buy, raising the price target from $29 to $31. The upgrade resulted in a slight gain for ArcelorMittal shares, settling at $23.47, up 0.3% on Tuesday.
Finally, Baird analyst Peter Arment has upgraded AeroVironment, Inc. (AVAV) from Neutral to Outperform, significantly increasing the price target from $161 to $220. The upgrade sparked a surge in AeroVironment shares, closing at $177.76, up 6.1% on Tuesday.
These analyst upgrades offer valuable insights into the potential trajectory of these companies. However, it’s essential to remember that these are just opinions, and market fluctuations can influence stock performance. As always, investors should conduct thorough research and consult with financial advisors before making any investment decisions.
